1life Healthcare EBIT

As of the most recent data (December 2022), ONEM shows a EBIT of $-420M. That compares with $-240M in the prior-year period — down 71.8% year over year. That is below the Healthcare sector average of $22B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ONEM's EBIT is now $-420M (was $-240M) — a 71.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether 1life Healthcare is outperforming or lagging.

The Healthcare sector average EBIT is about $22B. 1life Healthcare is at $-420M, which is lower that average. That is roughly 101.9% below the sector mean. Use the comparison chart on this page to see how ONEM stacks up against individual peers as well.

Tracking ONEM's ebit over time shows whether 1life Healthcare is scaling, shrinking, or reshaping that part of the business. The current reading is $-420M That compares with $-240M in the prior-year period — down 71.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has 1life Healthcare's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-420M) with ownership activity and broader fundamentals.